Cargando…
Making wider use of the world's most widely used vaccine: Bacille Calmette–Guérin revaccination reconsidered
Approximately 100 million newborn children receive Bacille Calmette–Guérin (BCG) annually, because vaccination is consistently protective against childhood tuberculous meningitis and miliary TB. By contrast, BCG efficacy against pulmonary TB in children and adults is highly variable, ranging from 0%...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Royal Society
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757998/ https://www.ncbi.nlm.nih.gov/pubmed/23904584 http://dx.doi.org/10.1098/rsif.2013.0365 |